|
Valiant navion stent grafts were implanted in the endovascular treatment of a unknown size taa.It was reported the patient presented emergently to emergency room approximately 2 years and 11 months post index procedure with complaints of chest pains.A computed tomography performed revealed a large mid descending thoracic aortic aneurysm.The physician noted that a type 1b or type iii endoleak may be occurring involving the piece placed most distal.This stent graft was confirmed as the (b)(4).It was said this 3rd distal piece had been placed just proximal to the celiac artery during the index procedure.Intervention was performed the following day, 3 valiant captivia's were implanted vamf2828c150t (v30592263) was implanted most proximal followed by vamf2828c150tu (v30592262) & vamf2828c100tu (v30592478).In addition to landing at the celiac, 5 endoanchors were placed in most distal aspect of that graft.A type iii endoleak was ruled out during the intervention.Per the physician the cause of the event is that the stent graft appeared to have shortened or moved somehow, exposing 3 cm of aorta and leading to an endoleak, with sac filling.No additional clinical sequalae were provided and the patient is fine.
|
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|